Immunodeficiencies in adulthood: lung disease manifestations and treatment options

C. Milito (Rome, Italy)

Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Session: PG6 Immunodeficiencies in lung diseases
Session type: Postgraduate Course
Number: 77
Disease area: -

WebcastSlide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Milito (Rome, Italy). Immunodeficiencies in adulthood: lung disease manifestations and treatment options. International Congress 2019 – PG6 Immunodeficiencies in lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Scleroderma lung disease: Risk factors and treatment options
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010

Chronic interstitial lung disease in children: diagnosis and treatment
Source: International Congress 2016 – PG6 Lung fibrosis and sarcoidosis
Year: 2016



Patients’ adherence to chronic treatment of pulmonary diseases
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Amyloid-and nonamyloid-deposition disease in the lung: novel manifestations
Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans
Year: 2013


Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016

The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Lymphoproliferative disease: prevention and management
Source: School Course 2012 - Lung Transplantation
Year: 2012


Symptoms management of advanced lung disease
Source: Annual Congress 2004 - Palliative care in lung disease
Year: 2004

Neonatal chronic lung disease and its long-term consequences
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=99
Year: 2002

Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice
Source: Eur Respir J 2013; 41: 1252-1256
Year: 2013



Clinical spectrum of children with interstitial pneumonia with autoimmune features:a new definition in childhood interstitial lung diseases
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


Early symptoms in lung cancer: the paraneoplasic syndromes
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013



Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006